Jonathan Hardin
Family Medicine · Mount Vernon, OHNPI 1427310473
Payments from drug & device makers
Across 293 payments — averaging $13.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$838
- AstraZeneca$572
- Pfizer$453
- GSK$355
- Novo Nordisk$324
- Lilly USA, LLC$179
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,845100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $838 |
| AstraZeneca | 39 | $572 |
| Pfizer | 32 | $453 |
| GSK | 31 | $355 |
| Novo Nordisk | 26 | $324 |
| Lilly USA, LLC | 13 | $179 |
| Merck | 17 | $177 |
| Biohaven Pharmaceuticals, Inc. | 16 | $124 |
| Bayer | 5 | $80 |
| Amgen | 5 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Amarin Pharma, Inc. | 4 | $66 |
| Boehringer Ingelheim | 4 | $59 |
| Grifols USA, LLC | 4 | $56 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Eisai Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Bioventus LLC | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
| Circassia Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLOGUARD$116
How this compares
$3,851 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 38 | $39,476 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $18,054 |
| OzempicSemaglutide | 19 | $17,652 |
| Repatha SureclickEvolocumab | 13 | $10,238 |
| EliquisApixaban | 12 | $9,598 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,298 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,800 |
| Rosuvastatin Calcium | 41 | $1,065 |
| Hydroxychloroquine Sulfate | 21 | $910 |
| Pravastatin Sodium | 51 | $727 |
| Tamsulosin Hcl | 27 | $457 |
| Metoprolol Succinate | 25 | $412 |
| Amlodipine Besylate | 73 | $346 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $346 |
| Diltiazem 24hr ErDiltiazem Hcl | 12 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $179 | $39,47638 claims |
| AstraZenecaBreztri Aerosphere | $572 | $18,05429 claims |
| Novo NordiskOzempic | $324 | $17,65219 claims |
| GSKAnoro Ellipta, Breo Ellipta | $355 | $10,09723 claims |
| PfizerEliquis | $453 | $9,59812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Mount Vernon
- Larry ReedMount Vernon$86K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.